2024-11-28 07:49:27
GenFleet Receives FDA Approval for Phase II Study of RIPK1 Inhibitor (GFH312)
Health/ 2023-07-22
GenFleet Receives FDA Approval for Phase...

SHANGHAI,Aug. 18,2022--GenFleet Therapeutics,a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immun...

WeTrade Group Inc. Ready to kick-off a Strategic Partnership with Zhixun Bio through WeTrade's SaaS platform and its the Internet of Things (IoT)
Corporate/ 2023-07-24
WeTrade Group Inc. Ready to kick-off a S...

BEIJING,Aug. 18,2022-- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG),an emerging growth company engaged...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release